Patrick A. Mayes
At a glance: Patrick A. Mayes is Evp & Chief Scientific Officer at Incyte (INCY). Their latest SEC Form 4, filed Aug 7, 2026, reported a sale of $274K. On file: 0 purchase lines ($0) and 15 sale lines ($6.6M).
Disclosed holdings: about $7.1M of INCY stock: 61,441 shares reported on their latest Form 4 (filed Aug 7, 2026), valued at the Nov 19, 2026 close of $115.96. This counts only INCY shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Evp & Chief Scientific Officer at Incyte Corp (INCY)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Patrick A. Mayes's InsiderPrint
15 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 15 times a year, typically $274K a trade; most sales are on a pre-planned 10b5-1 schedule; trades in the same month most years.
- Bump outward: a purchase (0)
- Dent inward: a sale (15)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Chad Michael WhalenEvp, Worldwide Sales · FFIV · 100% match
- Emma ReeveDirector · PTCT · 100% match
- Daniel Stanley PerottiCFO · PFSI · 100% match
- Joshua D. SchmidtGeneral Counsel · IDCC · 99% match
- Robert DennehyCOO · MTSI · 99% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 7SEC | INCYIncyte Corp | Sell Plan | 2,20761,441 held (−3%) | $123.99 | $274K | -6.5% |
| Aug 4SEC | INCYIncyte Corp | Sell Plan | 14,66188,679 held (−14%) | $119.46 | $1.8M | -2.9% |
| Aug 4SEC | INCYIncyte Corp | Sell Plan | 5,33283,347 held (−6%) | $119.42 | $637K | -2.9% |
| Aug 4SEC | INCYIncyte Corp | Sell Plan | 2,18781,160 held (−3%) | $119.47 | $261K | -2.9% |
| Aug 4SEC | INCYIncyte Corp | Sell Plan | 6,17174,989 held (−8%) | $119.43 | $737K | -2.9% |
| Aug 4SEC | INCYIncyte Corp | Sell Plan | 4,69570,294 held (−6%) | $119.39 | $561K | -2.9% |
| Aug 4SEC | INCYIncyte Corp | Sell Plan | 2,86467,430 held (−4%) | $119.40 | $342K | -2.9% |
| Aug 4SEC | INCYIncyte Corp | Sell Plan | 1,64365,787 held (−2%) | $119.51 | $196K | -3.0% |
| Aug 4SEC | INCYIncyte Corp | Sell Plan | 1,64264,145 held (−2%) | $119.38 | $196K | -2.9% |
| Aug 4SEC | INCYIncyte Corp | Sell Plan | 8564,060 held (−0%) | $122.19 | $10K | -5.1% |
| Aug 4SEC | INCYIncyte Corp | Sell Plan | 32663,734 held (−1%) | $121.69 | $40K | -4.7% |
| Aug 4SEC | INCYIncyte Corp | Sell Plan | 2,29361,441 held (−4%) | $119.41 | $274K | -2.9% |
| Aug 4SEC | INCYIncyte Corp | Sell Plan | 6,05561,441 held (−9%) | $120.43 | $729K | -3.7% |
| Dec 12SEC | INCYIncyte Corp | Sell Plan | 5,55360,266 held (−8%) | $95.58 | $531K | +21.3% |
| Dec 12SEC | INCYIncyte Corp | Sell Plan | 25560,011 held (−0%) | $94.94 | $24K | +22.1% |
- Sell
Evp & Chief Scientific Officer Patrick A Mayes sold $274K of INCY at $123.99 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp & Chief Scientific Officer Patrick A Mayes sold $1.8M of INCY at $119.46 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp & Chief Scientific Officer Patrick A Mayes sold $637K of INCY at $119.42 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp & Chief Scientific Officer Patrick A Mayes sold $261K of INCY at $119.47 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp & Chief Scientific Officer Patrick A Mayes sold $737K of INCY at $119.43 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp & Chief Scientific Officer Patrick A Mayes sold $561K of INCY at $119.39 — pre-scheduled 10b5-1 plan sale.
Follow Patrick A. Mayes
Get one email when Patrick A. Mayes files a new purchase or sale. Free.
At most one email a day about Patrick A. Mayes, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.